17 Rare Cancers You May Never Have Heard Of
Years ago, a family member was diagnosed with an extremely rare cancer: Liposarcoma of the Spermatic Cord. Fewer than 200 cases have been reported worldwide, making this diagnosis both a blessing and a challenge.
The rarity posed significant obstacles—there was little information available about effective treatments, and stories of survival were scarce. However, it also garnered the attention of top research hospitals, opening doors to exceptional care that might otherwise have been difficult to access. My family member was fortunate to have an outstanding doctor, supported by a global network of specialists and researchers. After a harrowing year of surgeries and radiation, I am profoundly grateful to share that they remain a rare survivor of this cancer, now nine years on.
As I was reflecting back on this experience, I wondered what other cancers are equally if not similarly rare – and how patients run up against the same kind of challenges my family member did in navigating the unknown and the less charted map for healthcare.
While common cancers like breast, lung, and colorectal often dominate health discussions, rare cancers affect thousands of people each year. These uncommon malignancies can be challenging to diagnose and treat due to limited research and awareness. This article explores 17 of the rarest types of cancer, examining their prevalence, survival rates, and symptoms.
Liposarcoma of the Spermatic Cord
Prevalence: Extremely rare, with fewer than 200 cases reported worldwide. Annual incidence of spermatic cord tumors is approximately 0.3 cases per million. Remission or death likelihood: 5-year survival rates vary based on grade. Well-differentiated: Approximately 85%, Myxoid: Around 77%, Pleomorphic: About 20%. Early symptoms: Painless scrotal or inguinal swelling. Slow-growing mass in the scrotum or inguinal region. Onset symptoms: Increased size of the mass. Possible pain or discomfort. Rarely, symptoms related to metastasis in advanced cases
Liposarcoma of the spermatic cord is an extremely rare malignancy that often presents as a painless, slow-growing mass. It can be mistaken for more common conditions like hernias or benign tumors, making early diagnosis challenging. Radical orchiectomy with wide excision is the primary treatment, and long-term follow-up is crucial due to the risk of late recurrence.
Merkel Cell Carcinoma
A rare but aggressive skin cancer that typically affects older adults. It often appears as a fast-growing, painless nodule on sun-exposed areas. Merkel cell carcinoma is a rare and aggressive skin cancer, with approximately 3,000 cases diagnosed annually in the United States. This cancer has a 40% 5-year recurrence rate. Early symptoms include a painless, firm, shiny bump on the skin, often with a reddish-purple color. As the disease progresses, rapid growth of the bump and potential metastasis to lymph nodes may occur.
Glioblastoma
Glioblastoma, an aggressive brain cancer, affects 3.19 to 4.17 per 100,000 people. With a sobering 5% 5-year survival rate, it’s one of the deadliest rare cancers. Early symptoms can include headaches, seizures, nausea, and personality changes. As the tumor grows, patients may experience severe headaches, vomiting, and cognitive decline.
Ewing Sarcoma
Ewing sarcoma, a bone cancer primarily affecting children and young adults, occurs in about 1 case per 1 million people annually. The 5-year survival rate is approximately 62.47%. Early symptoms include pain and swelling around the tumor site, fever, weight loss, and fatigue. As the disease progresses, patients may experience severe pain, swelling, and, in some cases, paralysis if the spine is affected.
Adrenocortical Carcinoma
A rare and aggressive cancer of the adrenal cortex, which is the outer layer of the adrenal glands. It can affect hormone production. This rare cancer of the adrenal glands affects 0.5 to 2 cases per million people annually. The 5-year survival rate ranges from 15% to 44%. Early symptoms may include abdominal pain, a lump in the abdomen, and excessive hair growth. As the cancer advances, patients might experience severe abdominal pain, weight loss, and hormonal changes.
Gallbladder Cancer
Gallbladder cancer occurs in about 1.13 cases per 100,000 people annually. The 5-year survival rate is approximately 20%. Early symptoms can be vague, including abdominal pain, nausea, and jaundice. As the disease progresses, patients may experience severe abdominal pain, vomiting, jaundice, and loss of appetite.
Cholangiocarcinoma
Cholangiocarcinoma, or bile duct cancer, affects 1.49 per 100,000 people annually. The 5-year survival rate is a low 9.8%. Early symptoms include jaundice, fatigue, and abdominal pain. As the cancer advances, patients may experience severe abdominal pain, weight loss, and fever.
Neuroendocrine Tumors
Neuroendocrine tumors (NETs) are rare, abnormal growths that develop in the neuroendocrine system, which is made up of nerve and gland cells. Neuroendocrine tumors occur in about 8.19 per 100,000 people. The 5-year survival rates range from 53% to 94%, depending on the specific type and stage. Early symptoms can include fatigue, abdominal pain, and nausea. As the disease progresses, patients may experience severe abdominal pain, diarrhea, and flushing.
Penile Cancer
Penile cancer is a rare type of cancer that affects the skin or tissues of the penis. Penile cancer affects about 0.84 cases per 100,000 person-years. The 5-year survival rate is approximately 65%. Early symptoms include skin changes, growths or lesions on the penis, and foul-smelling discharge. As the cancer advances, patients may experience severe pain, bleeding, and changes in skin color.
Small Bowel Adenocarcinoma
This rare cancer occurs in 2.1 per 100,000 males and 1.6 per 100,000 females. The 5-year survival rate is about 70.2%. Early symptoms can include abdominal pain, weight loss, nausea, and vomiting. As the disease progresses, patients may experience gastrointestinal bleeding and changes in bowel habits.
Ocular Melanoma
Ocular melanoma, a rare eye cancer, affects approximately 0.83 per 100,000 people annually. The 5-year survival rate is about 69%, dropping to 40% at 10 years. Early symptoms include blurred vision, dark spots on the iris, and flashes of light. As the cancer advances, patients may experience severe vision loss and eye bulging.
Cardiac (Heart) Cancer
Extremely rare since the heart is a low-risk environment for cancer development. Most cases are sarcomas or myxomas, usually found in the heart’s connective tissue. Cardiac cancer is sporadic, with a prevalence of 0.8% among all cardiac tumors. The overall 5-year survival rate is approximately 11.5%. Early symptoms may include chest pain, shortness of breath, and irregular heartbeat. As the disease progresses, patients might experience severe fatigue, swelling in the legs, and fluid accumulation in the lungs.
Extragonadal Germ Cell Tumors
These tumors arise in areas outside the gonads (e.g., brain, chest, abdomen) where germ cells are abnormally located. These rare tumors have an incidence of about 1 in 1,000,000. Survival rates vary depending on the location and stage of the cancer. Early symptoms can include chest pain, cough, and difficulty breathing for mediastinal tumors, or abdominal pain and swelling for retroperitoneal tumors. Advanced cases may present with neurological symptoms if the brain is affected.
Chordoma
Chordoma is a rare, slow-growing, malignant bone tumor that can occur in the spine or base of the skull. Chordoma affects approximately 1 in 1,000,000 people annually. The 5-year survival rate is about 68%. Early symptoms include pain and neurological deficits depending on the tumor’s location. As the disease progresses, patients may experience severe pain, difficulty walking, and loss of bladder or bowel control.
Esthesioneuroblastoma (Olfactory Neuroblastoma)
This rare nasal cavity cancer has a 5-year survival rate of approximately 62.1%. Early symptoms include nasal congestion, nosebleeds, and loss of smell. As the tumor grows, patients may experience headaches, vision changes, and facial pain or numbness.
Pseudomyxoma Peritonei (PMP)
A rare cancer that starts in the appendix or other abdominal organs and produces a jelly-like substance, spreading within the abdominal cavity. PMP affects about 1 in 1,000,000 people annually. The 5-year survival rate can range from 50% to 96%, depending on the grade and treatment. Early symptoms are often vague and include abdominal pain, bloating, and changes in bowel habits. As the disease progresses, patients may experience severe abdominal distension, difficulty eating, and weight loss.
Vaginal Cancer
Primary cancer of the vagina is rare and often involves squamous cell carcinoma or adenocarcinoma. It is much rarer compared to cervical or uterine cancer. Prevalence: 0.36 cases per 100,000 women. Remission or death likelihood: 69% for localized, 26% for distant spread. Early symptoms: Abnormal vaginal bleeding (often after sex), abnormal vaginal discharge, a mass or lump in the vagina that can be felt. Onset symptoms: Painful urination, constipation, pain in the pelvis or low in the belly, back pain, swelling in the legs.
Conclusion
While these rare cancers may not make headlines as often as their more common counterparts, understanding their symptoms and prevalence is crucial for early detection and treatment. As research continues, hope remains for improved diagnostic methods and treatment options for these uncommon yet impactful diseases. May anyone suffering from any of these have the same fortunate outcome as my family member.
References:
- https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2020.566408/full
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8305359/
- https://www.cancercenter.com/community/blog/2023/02/heart-cancer-prevalence-and-symptoms
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6853824/
- https://rarediseases.org/rare-diseases/chordoma/
- https://www.pacificneuroscienceinstitute.org/brain-tumor/conditions/olfactory-neuroblastoma-sinonasal-cancers/
- https://rarediseases.org/rare-diseases/pseudomyxoma-peritonei/
- https://www.cancer.org/cancer/types/vaginal-cancer/detection-diagnosis-staging/signs-symptoms.html
- https://en.wikipedia.org/wiki/Angiosarcoma
- https://amj.amegroups.org/article/view/5412/html
- https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.27403
- https://www.ucsfbenioffchildrens.org/conditions/germ-cell-tumors
- https://chordoma-uk.org/diagnosis-and-treatment
- https://emedicine.medscape.com/article/278047-overview
- https://www.pseudomyxomasurvivor.org/what-are-the-statistics-for-pseudomyxoma-peritonei/
- https://ocrahope.org/for-patients/gynecologic-cancers/vaginal-cancer/
You May Also Want To Read:
- How To Appeal A Denied Health Insurance Claim Successfully
- 10 Ways To Tell If You Are Going Insane
- Hypertension Risk: Early Signs Of This Silent Killer
Join Us
Join us on this empowering journey as we explore, celebrate, and elevate “her story.” The Queen Zone is not just a platform; it’s a community where women from all walks of life can come together, share their experiences, and inspire one another. Welcome to a space where the female experience takes center stage. Sign up for our newsletter so you don’t miss a thing, Queen!
